Promising Drugs Against Tuberculosis

Author(s): Marcus V. N. de Souza

Journal Name: Recent Patents on Anti-Infective Drug Discovery
Continued as Recent Advances in Anti-Infective Drug Discovery

Volume 1 , Issue 1 , 2006

Become EABM
Become Reviewer
Call for Editor


Tuberculosis (TB) is an important public health problem worldwilde due to AIDS epidemic, the advent of multidrug resistant strains (MDR) and the lack of new drugs in the market. TB is responsible for almost 3 millions deaths each year. According to WHO (World Health Organization), which declared tuberculosis a global health emergency in 1993, tuberculosis, without a coordinated control effort, will infect an estimated 1 billion people by 2020, killing 70 million. In spite of this problem, there is a lack of development of new TB drugs. For example, it has been nearly 35 years since the introduction of a new class of compounds for the treatment of TB. Thus, there is an urgent need for new drugs to fight against this disease. Considering that, this review aims promising drug candidates that are in development against TB.

Keywords: Tuberculosis, drugs, antimycobacterial activity

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [33 - 44]
Pages: 12
DOI: 10.2174/157489106775244163

Article Metrics

PDF: 31